Literature DB >> 1716353

Corneal staining after sequential instillations of fluorescein over 30 days.

B E Caffery, J E Josephson.   

Abstract

The corneal staining patterns of 6 healthy female subjects were monitored Monday through Friday for 4 consecutive weeks using daily sequential instillations of fluorescein. The patterns showed that in these subjects there was no predictable pattern of staining, that each subject had different staining characteristics, and that corneal staining varied day to day.

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1716353     DOI： 10.1097/00006324-199106000-00011

Source DB:  PubMed          Journal:  Optom Vis Sci        ISSN： 1040-5488            Impact factor:   1.973


  10 in total

Review 1.  The international workshop on meibomian gland dysfunction: report of the subcommittee on management and treatment of meibomian gland dysfunction.

Authors:  Gerd Geerling; Joseph Tauber; Christophe Baudouin; Eiki Goto; Yukihiro Matsumoto; Terrence O'Brien; Maurizio Rolando; Kazuo Tsubota; Kelly K Nichols
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-03-30       Impact factor: 4.799

2.  Tear lipocalin: evidence for a scavenging function to remove lipids from the human corneal surface.

Authors:  Oktay K Gasymov; Adil R Abduragimov; Pawan Prasher; Taleh N Yusifov; Ben J Glasgow
Journal:  Invest Ophthalmol Vis Sci       Date:  2005-10       Impact factor: 4.799

Review 3.  New approaches for diagnosis of dry eye disease.

Authors:  Abdelrahman M Elhusseiny; Ali A Khalil; Reem H El Sheikh; Mohammad A Bakr; Mohamed Gaber Eissa; Yasmine M El Sayed
Journal:  Int J Ophthalmol       Date:  2019-10-18       Impact factor: 1.779

4.  Fluorescein punctate staining traced to superficial corneal epithelial cells by impression cytology and confocal microscopy.

Authors:  Maryam Mokhtarzadeh; Richard Casey; Ben J Glasgow
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-04-05       Impact factor: 4.799

5.  Efficiency and safety of subconjunctival injection of anti-VEGF agent - bevacizumab - in treating dry eye.

Authors:  Xiaodan Jiang; Huibin Lv; Weiqiang Qiu; Ziyuan Liu; Xuemin Li; Wei Wang
Journal:  Drug Des Devel Ther       Date:  2015-06-12       Impact factor: 4.162

6.  Evaluation of the Safety and Effectiveness of Intense Pulsed Light in the Treatment of Meibomian Gland Dysfunction.

Authors:  Xiaodan Jiang; Huibin Lv; Hang Song; Mingzhou Zhang; Yan Liu; Xiaodan Hu; Xuemin Li; Wei Wang
Journal:  J Ophthalmol       Date:  2016-06-20       Impact factor: 1.909

7.  Efficacy of intra-meibomian gland injection of the anti-VEGF agent bevacizumab for the treatment of meibomian gland dysfunction with lid-margin vascularity.

Authors:  Xiaodan Jiang; Yuexin Wang; Huibin Lv; Yan Liu; Mingzhou Zhang; Xuemin Li
Journal:  Drug Des Devel Ther       Date:  2018-05-16       Impact factor: 4.162

8.  Corneal Swelling with Cosmetic etafilcon A Lenses versus No Lens Wear.

Authors:  Amir M Moezzi; Jalaiah Varikooty; Marc Schulze; William Ngo; Kathrine Osborn Lorenz; Danielle Boree; Lyndon W Jones
Journal:  Optom Vis Sci       Date:  2016-06       Impact factor: 1.973

9.  Short break-up time type dry eye has potential ocular surface abnormalities.

Authors:  Yoshiyuki Ichihashi; Takeshi Ide; Minako Kaido; Reiko Ishida; Shin Hatou; Kazuo Tsubota
Journal:  Taiwan J Ophthalmol       Date:  2015-05-04

10.  Pathogens in the Meibomian gland and conjunctival sac: microbiome of normal subjects and patients with Meibomian gland dysfunction.

Authors:  Xiaodan Jiang; Aihua Deng; Jiarui Yang; Hua Bai; Zhao Yang; Jie Wu; Huibin Lv; Xuemin Li; Tingyi Wen
Journal:  Infect Drug Resist       Date:  2018-10-11       Impact factor: 4.003
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.